Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
70 participants
OBSERVATIONAL
2019-09-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
All patients undergo polysomnography (PSG) and drug-induced sleep endoscopy(DISE). The biological specimens was obtained for molecular biology or other tests.We detected Claudin1, Claudin2, Claudin3, Claudin4, and IL22 as biomarkers to differentiate the diagnostic efficiency of OSA in ILD, ILD+OSA, OSA, and Ctrl groups, respectively
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevalence of OSA in Patients of ILD
NCT06058052
The Induction of IL-6 by NF-kB in PBMC in OSA
NCT00498381
The Study of Sleep Disordered Breathing in Patients With Interstitial Lung Diseases
NCT06012526
Predictors of OSA in Patients With COPD
NCT05605431
Clinical Characteristics and Molecular Mechanism of Patients With Obstructive Sleep Apnea
NCT07277608
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ILD with OSA group
ILD patient diagnosed with OSA by PSG. Bronchoscopy was performed to obtain alveolar lavage fluid in ILD patients and lung tissue was obtained for ROSE and mNGS in appropriate patients
The relationship between imaging and ROSE and NGS
The correlation between ROSE and NGS in imaging and bronchoscopy of ILD patients was observed
ILD without OSA
ILD patients excluded OSA through PSG. Bronchoscopy was performed to obtain alveolar lavage fluid in ILD patients and lung tissue was obtained for ROSE and mNGS in appropriate patients
The relationship between imaging and ROSE and NGS
The correlation between ROSE and NGS in imaging and bronchoscopy of ILD patients was observed
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
The relationship between imaging and ROSE and NGS
The correlation between ROSE and NGS in imaging and bronchoscopy of ILD patients was observed
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical diagnosis of interstitial lung disease or obstructive respiratory sleep apnea syndrome.
* Patient is conscious and capable of signing informed consent.
* The patient may wear a polysomnograph.
Exclusion Criteria
* severe heart failure.
* uremia.
* autoimmune diseases.
* pulmonary embolism, and end-stage chronic obstructive pulmonary disease.
* Patients with mental illnesscannot sign informed consent on their own.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dan Liu
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dan Liu
Master of Medicine, attending physician
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tianjin Medical University General Hospital
Tianjin, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Dliu
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.